论文部分内容阅读
目的：观察多烯康与阿昔洛韦治疗带状疱疹的疗效比较。方法：７８例带状疱疹病人随机分为多烯康治疗组，男性３０例，女性９例，年龄４０±ｓ２０ａ，多烯康胶丸１．３５ｇ，ｐｏ，ｔｉｄ×１０ｄ；阿昔洛韦对照组，男性２８例，女性１１例，年龄４１±２２ａ，阿昔洛韦０．２ｇ，ｑｉｄ×１０ｄ。结果：多烯康组和阿昔洛韦组的治愈例数、治愈天数、止痛天数分别为３９例，１１±３ｄ，３．８±１．２ｄ和３８例，１０．６±２．９ｄ，４．０±１．５ｄ，差异不显著（Ｐ＞０．０５）；毒副作用：多烯康组为１例（１／３９）少于阿昔洛韦组（８例，８／３９），差异显著（Ｐ＜０．０５）。结论：多烯康治疗带状疱疹有效，毒副作用少。
OBJECTIVE: To observe the curative effect of Duoxikang and acyclovir in the treatment of shingles. Methods: A total of 78 patients with herpes zoster were randomly divided into two groups, 30 males and 9 females, aged 40 ± s20a, 1.35g, po, tid × 10d for dolecone capsules, Group, 28 males and 11 females, age 41 ± 22a, acyclovir 0.2g, qid × 10d. Results: The cured cases, the cured days and the analgesic days in the doxycycline group and the acyclovir group were 39 cases, 11 ± 3d, 3.8 ± 1.2d and 38 cases, respectively, 10.6 ± 2.9 days, 4.0 ± 1.5d, the difference was not significant (P> 0.05). Toxicity and side effects: Doceconazole group was less than acyclovir in 1 case (1/39) (8/8/39) The difference was significant (P <0.05). Conclusion: Duoxikang treatment of shingles effective, less side effects.